A marker for Stevens-Johnson syndrome …: ethnicity matters
Top Cited Papers
Open Access
- 17 January 2006
- journal article
- research article
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 6 (4), 265-268
- https://doi.org/10.1038/sj.tpj.6500356
Abstract
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but severe cutaneous adverse drug reactions, which can be caused by a certain number of specific drugs among which is carbamazepine, an antiepileptic agent. A very strong association of carbamazepine-induced SJS with HLA-B*1502 has recently been described in the Han Chinese population. Here in, we report preliminary results from a European study (RegiSCAR) of 12 carbamazepine-induced SJS/TEN cases (nine French and three German). Among these only four had a HLA-B*1502 allele. Remarkably, these four patients had an Asian ancestry, whereas the others did not as far as we have ascertained. This shows that although the HLA region may contain important genes for SJS, the HLA-B*1502 allele is not a universal marker for this disease and that ethnicity matters.Keywords
This publication has 16 references indexed in Scilit:
- Toxic epidermal necrolysis: Effector cells are drug-specific cytotoxic T cellsJournal of Allergy and Clinical Immunology, 2004
- A marker for Stevens–Johnson syndromeNature, 2004
- Induction of T‐cell‐mediated skin disease specific for antigen transgenically expressed in keratinocytesEuropean Journal of Immunology, 2003
- Association between presence of HLA-B*5701, HLA-DR7 , and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavirThe Lancet, 2002
- Genetic variations in HLA-B region and hypersensitivity reactions to abacavirThe Lancet, 2002
- Nevirapine and the risk of Stevens–Johnson syndrome or toxic epidermal necrolysisAIDS, 2001
- Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?Clinical Genetics, 1999
- Inhibition of Toxic Epidermal Necrolysis by Blockade of CD95 with Human Intravenous ImmunoglobulinScience, 1998
- Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal NecrolysisNew England Journal of Medicine, 1995
- MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activationCell, 1994